Support
Tutorials
+1-302-789-0447
support@cloudlims.com
Webinar Overview
The importance of informed consent in clinical research cannot be overstated. Clinical researchers must obtain participants’ consent for their voluntary participation in research. Furthermore, they must explain the purpose and risks associated with the study to participants in a language they can comprehend. The process of creating informed consent documents can be challenging, as it involves meeting several regulatory requirements and understanding the fundamentals of writing informed consent. The webinar delineates these requirements and explains how to effectively write informed consent to meet regulatory requirements and protect participants’ rights and privacy at all times. The webinar also emphasizes the importance of using a laboratory software for clinical research to automate and streamline the management of informed consent.
Key Takeaways
- What is informed consent and why it is important for clinical research
- Tips for writing informed consent effectively to meet regulatory requirements
- How a LIMS for clinical research supports informed consent management and drives research
Who Should Watch
Recommended attendees include lab managers, directors, quality managers, and technicians of clinical research and clinical trial labs.
Please fill the form to watch the webinar
SPEAKER
Martha Hernández
Scientist, CloudLIMS.com
Martha is a chemist with expertise in diverse areas of analytical chemistry. She had worked as an analyst at a licensed 3rd party analytical laboratory where she focused on developing and validating analytical methods for bioequivalence studies. Later, she served as a quality control expert in the analytical domain and as a monitor in clinical trials. Her interest in the clinical industry led her to be a part of two of the biggest hospitals in Mexico where she gained expertise in hematology, microbiology, and blood banking. Later, she became a member of the team of forensic chemical experts and started working from day one as a specialist in narcotics and drugs. This enabled her to gain rich experience in GC-MS, FTIR, HPLC-MS/MS, ICP-MS, and other analytical techniques for the separation, detection, and quantification of different molecules such as cannabinoids. She had participated in multiple oral trials defending her legal opinions and worked as an expert consultant. She had worked on the synthesis of small molecules for testing them on multi-drug resistant bacteria and mycobacteria, further developing her analytical skills in column chromatography, thin-layer chromatography, microbiology, and compound elucidation by NMR and HRMS. She carried out a research stay at the University of Barcelona with the organic synthesis team. She had also worked on natural products in France and presented her work at conferences in the USA and France. She received awards and accolades for her exceptional work. She has participated in several conferences as a moderator as well.
Martha holds a bachelor’s degree in Clinical Chemistry from the Faculty of Medicine UANL and a master’s degree in Pharmacy from the Faculty of Chemical Sciences UANL, Mexico.